US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

2.94

-0.4700-13.78%

Post-market: 2.93-0.0100-0.34%19:59 EDT

Volume:701.51K

Turnover:2.15M

Market Cap:13.23M

PE:-0.14

High:3.22

Open:3.20

Low:2.94

Close:3.41

52wk High:67.12

52wk Low:2.34

Shares:4.50M

Float Shares:4.50M

Volume Ratio:0.16

T/O Rate:15.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-20.7848

EPS(LYR):-22.3665

ROE:-1802.45%

ROA:-110.27%

PB:-6.19

PE(LYR):-0.13

Loading ...

Overview Company News Filings

bioAffinity Stock Up Over 50%: What's Driving the Surge?

Benzinga_recent_news

bioAffinity Technologies Announces New Clinical Case Studies Demonstrating CyPath® Lung's Success in Early-Stage Cancer Detection and Reducing Unnecessary Procedures

bioAffinity Technologies Inc. Files Initial Statement of Beneficial Ownership for Director John J. Oppenheimer

bioAffinity Technologies Inc trading halted, news pending

BioAffinity Technologies announces 1-for-30 reverse split

bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025

THOMSON REUTERS

BRIEF-Bioaffinity Technologies Appoints New Members To Board Of Directors

bioAffinity Technologies Announces New Board Appointments: Roberto Rios and Dr. John J. Oppenheimer Join as Directors

bioAffinity Technologies Appoints New Members to Board of Directors

THOMSON REUTERS

bioAffinity Technologies Reports 62% Increase in CyPath® Lung Revenues for First Half of 2025

bioAffinity Technologies Q2 EPS $(0.17) Misses $(0.10) Estimate, Sales $1.269M Miss $1.506M Estimate

bioAffinity Technologies Announces $1.2 Million Private Placement and Warrant Inducement Transaction

bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds

THOMSON REUTERS

bioAffinity Technologies Inc expected to post a loss of 10 cents a share - Earnings Preview

Case Study: Cypath® Lung Detects Stage 1a Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results

THOMSON REUTERS

bioAffinity Technologies Inc. Conducted Annual Stockholders Meeting

bioAffinity Technologies Secures Canadian Patent for Innovative Lung Cancer Diagnostic Test, CyPath® Lung

bioAffinity Technologies Receives Notification of Patent Allowance in China for Noninvasive Lung Cancer Diagnostic

bioAffinity Technologies Announces Patent Filing for Broad-Spectrum Cancer Therapy Using siRNA Technology

bioAffinity Technologies Secures Chinese Patent for Innovative siRNA-Based Cancer Therapy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BIAF/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIAF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAF\",,,,,undefined,":{"symbol":"BIAF","market":"US","secType":"STK","nameCN":"bioAffinity Technologies, Inc.","latestPrice":2.94,"timestamp":1760731200000,"preClose":3.41,"halted":0,"volume":701506,"hourTrading":{"tag":"盘后","latestPrice":2.93,"preClose":2.94,"latestTime":"19:59 EDT","volume":16268,"amount":47900.3795,"timestamp":1760745583033},"delay":0,"floatShares":4497867,"shares":4498700,"eps":-20.78478,"marketStatus":"Market Closed","change":-0.47,"latestTime":"10-17 16:00:00 EDT","open":3.2,"high":3.2199,"low":2.94,"amount":2150769.2025377997,"amplitude":0.082082,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-20.78478,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":3.41,"preHourTrading":{"tag":"盘前","latestPrice":3.12,"preClose":3.41,"latestTime":"09:29 EDT","volume":76809,"amount":236170.930638,"timestamp":1760707798096},"postHourTrading":{"tag":"盘后","latestPrice":2.93,"preClose":2.94,"latestTime":"19:59 EDT","volume":16268,"amount":47900.3795,"timestamp":1760745583033},"volumeRatio":0.15730427486988605},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAF\",,,,,undefined,":{"symbol":"BIAF","floatShares":4497867,"roa":"-110.27%","roe":"-1802.45%","lyrEps":-22.36653,"volumeRatio":0.15730427486988605,"shares":4498700,"dividePrice":0,"high":3.2199,"amplitude":0.082082,"preClose":3.41,"low":2.94,"week52Low":2.3401,"pbRate":"-6.19","psRate":"1.72","week52High":67.116,"institutionHeld":0,"latestPrice":2.94,"eps":-20.78478,"divideRate":0,"volume":701506,"delay":0,"ttmEps":-20.78478,"open":3.2,"prevYearClose":27.3,"prevWeekClose":2.72,"prevMonthClose":2.96,"prevQuarterClose":2.96,"fiveDayClose":2.72,"twentyDayClose":4.98,"sixtyDayClose":10.413},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIAF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-19","symbol":"BIAF","defaultRemindTime":1758288600000,"type":"split","dateTimestamp":1758254400000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-08-14","symbol":"BIAF","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2025-05-15","symbol":"BIAF","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2025-03-31","symbol":"BIAF","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2024-05-15","symbol":"BIAF","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"pre","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIAF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIAF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIAF\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIAF","date":"2025-10-17","current":-0.14145,"percent":0.680965,"low":-7.049629,"twenty":-2.475863,"median":-1.832728,"eighty":-1.022005,"high":-0.204609,"avg":-1.835766,"sd":0.910459,"marketCap":15308437},"quantilePoints":[{"date":"2022-06-24","current":-2.566585,"twenty":-2.566585,"median":-2.566585,"eighty":-2.566585,"marketCap":18177210},{"date":"2022-06-27","current":-2.566585,"twenty":-2.566585,"median":-2.566585,"eighty":-2.566585,"marketCap":18177210},{"date":"2022-08-11","current":-2.358916,"twenty":-2.566585,"median":-2.358916,"eighty":-2.358916,"marketCap":16706445},{"date":"2022-09-02","current":-5.987938,"twenty":-4.619397,"median":-2.46275,"eighty":-2.358916,"marketCap":51799882},{"date":"2022-09-09","current":-4.059907,"twenty":-4.863395,"median":-3.313246,"eighty":-2.358916,"marketCap":35121054},{"date":"2022-09-16","current":-3.652217,"twenty":-4.741088,"median":-3.89853,"eighty":-2.40045,"marketCap":31594254},{"date":"2022-09-23","current":-1.792135,"twenty":-4.487981,"median":-3.376177,"eighty":-2.358916,"marketCap":15503227},{"date":"2022-09-30","current":-2.471617,"twenty":-4.114265,"median":-2.819851,"eighty":-2.358916,"marketCap":21381227},{"date":"2022-10-07","current":-2.505591,"twenty":-4.053112,"median":-2.557322,"eighty":-2.358916,"marketCap":21675127},{"date":"2022-10-14","current":-2.225304,"twenty":-4.000452,"median":-2.497097,"eighty":-2.347154,"marketCap":19250452},{"date":"2022-10-21","current":-2.216811,"twenty":-3.849267,"median":-2.475863,"eighty":-2.347154,"marketCap":19176977},{"date":"2022-10-28","current":-2.378188,"twenty":-3.625038,"median":-2.463123,"eighty":-2.315336,"marketCap":20573002},{"date":"2022-11-04","current":-2.233798,"twenty":-3.460264,"median":-2.45463,"eighty":-2.315336,"marketCap":19323927},{"date":"2022-11-11","current":-2.403668,"twenty":-3.212252,"median":-2.420656,"eighty":-2.252484,"marketCap":20793427},{"date":"2022-11-18","current":-1.777191,"twenty":-3.05767,"median":-2.378188,"eighty":-2.225304,"marketCap":21426560},{"date":"2022-11-25","current":-1.80496,"twenty":-2.819851,"median":-2.378188,"eighty":-2.131876,"marketCap":21761350},{"date":"2022-12-02","current":-2.040993,"twenty":-2.666968,"median":-2.361201,"eighty":-1.922976,"marketCap":24607065},{"date":"2022-12-09","current":-1.402315,"twenty":-2.566585,"median":-2.358916,"eighty":-1.874381,"marketCap":16906895},{"date":"2022-12-16","current":-1.367604,"twenty":-2.566585,"median":-2.344214,"eighty":-1.832728,"marketCap":16488407},{"date":"2022-12-23","current":-1.284298,"twenty":-2.548059,"median":-2.305993,"eighty":-1.80496,"marketCap":15484037},{"date":"2022-12-30","current":-1.110745,"twenty":-2.514085,"median":-2.255032,"eighty":-1.798929,"marketCap":13391600},{"date":"2023-01-06","current":-1.110745,"twenty":-2.500495,"median":-2.242292,"eighty":-1.623075,"marketCap":13391600},{"date":"2023-01-13","current":-1.152467,"twenty":-2.486905,"median":-2.225304,"eighty":-1.388472,"marketCap":13894621},{"date":"2023-01-20","current":-1.055207,"twenty":-2.476713,"median":-2.174343,"eighty":-1.310679,"marketCap":12722020},{"date":"2023-01-27","current":-1.994133,"twenty":-2.468219,"median":-2.120828,"eighty":-1.310679,"marketCap":24042106},{"date":"2023-02-03","current":-1.652232,"twenty":-2.463123,"median":-2.040993,"eighty":-1.338447,"marketCap":19920005},{"date":"2023-02-10","current":-1.423211,"twenty":-2.459726,"median":-1.972439,"eighty":-1.375935,"marketCap":17158824},{"date":"2023-02-17","current":-1.430084,"twenty":-2.45463,"median":-1.922976,"eighty":-1.388459,"marketCap":17241685},{"date":"2023-02-24","current":-1.249588,"twenty":-2.45463,"median":-1.909092,"eighty":-1.350943,"marketCap":15065550},{"date":"2023-03-03","current":-1.214877,"twenty":-2.449534,"median":-1.839671,"eighty":-1.294017,"marketCap":14647062},{"date":"2023-03-10","current":-1.062149,"twenty":-2.42745,"median":-1.832728,"eighty":-1.249588,"marketCap":12805717},{"date":"2023-03-17","current":-1.166282,"twenty":-2.417258,"median":-1.815373,"eighty":-1.209323,"marketCap":14061180},{"date":"2023-03-24","current":-1.270414,"twenty":-2.398572,"median":-1.80496,"eighty":-1.202381,"marketCap":15316642},{"date":"2023-03-31","current":-1.312067,"twenty":-2.378188,"median":-1.80496,"eighty":-1.207935,"marketCap":15818827},{"date":"2023-04-06","current":-1.847601,"twenty":-2.378188,"median":-1.802794,"eighty":-1.200992,"marketCap":15065550},{"date":"2023-04-14","current":-1.652577,"twenty":-2.378188,"median":-1.800628,"eighty":-1.207935,"marketCap":13475297},{"date":"2023-04-21","current":-1.888933,"twenty":-2.378188,"median":-1.802794,"eighty":-1.207935,"marketCap":15402574},{"date":"2023-04-28","current":-2.034236,"twenty":-2.369694,"median":-1.80496,"eighty":-1.214877,"marketCap":16587387},{"date":"2023-05-05","current":-2.060629,"twenty":-2.361201,"median":-1.805752,"eighty":-1.214877,"marketCap":16802598},{"date":"2023-05-12","current":-1.945568,"twenty":-2.358916,"median":-1.818844,"eighty":-1.221819,"marketCap":15864382},{"date":"2023-05-18","current":-1.86888,"twenty":-2.358916,"median":-1.832728,"eighty":-1.232926,"marketCap":15352628},{"date":"2023-05-26","current":-1.991074,"twenty":-2.358916,"median":-1.839671,"eighty":-1.244034,"marketCap":16356443},{"date":"2023-06-01","current":-1.897743,"twenty":-2.358916,"median":-1.843636,"eighty":-1.249588,"marketCap":15589735},{"date":"2023-06-09","current":-2.001445,"twenty":-2.355976,"median":-1.86888,"eighty":-1.249588,"marketCap":16441633},{"date":"2023-06-16","current":-1.856262,"twenty":-2.342515,"median":-1.871631,"eighty":-1.249588,"marketCap":15248975},{"date":"2023-06-23","current":-1.794041,"twenty":-2.33572,"median":-1.857029,"eighty":-1.249588,"marketCap":14737837},{"date":"2023-06-30","current":-1.845892,"twenty":-2.315336,"median":-1.851932,"eighty":-1.249588,"marketCap":15163786},{"date":"2023-07-07","current":-1.928853,"twenty":-2.305144,"median":-1.856262,"eighty":-1.253753,"marketCap":15845304},{"date":"2023-07-14","current":-1.825151,"twenty":-2.276266,"median":-1.847601,"eighty":-1.26486,"marketCap":14993406},{"date":"2023-07-21","current":-1.866632,"twenty":-2.254183,"median":-1.846747,"eighty":-1.270414,"marketCap":15334165},{"date":"2023-07-28","current":-1.877002,"twenty":-2.250785,"median":-1.845892,"eighty":-1.273191,"marketCap":15419355},{"date":"2023-08-04","current":-1.835522,"twenty":-2.247388,"median":-1.846747,"eighty":-1.285686,"marketCap":15078596},{"date":"2023-08-11","current":-1.887373,"twenty":-2.232099,"median":-1.845892,"eighty":-1.294017,"marketCap":15504545},{"date":"2023-08-18","current":-1.62887,"twenty":-2.225304,"median":-1.842782,"eighty":-1.306513,"marketCap":16072062},{"date":"2023-08-24","current":-1.607329,"twenty":-2.225304,"median":-1.839463,"eighty":-1.312067,"marketCap":15859525},{"date":"2023-09-01","current":-1.53986,"twenty":-2.21851,"median":-1.835522,"eighty":-1.312067,"marketCap":15193808},{"date":"2023-09-08","current":-1.530959,"twenty":-2.199824,"median":-1.835522,"eighty":-1.314844,"marketCap":15105982},{"date":"2023-09-14","current":-1.44195,"twenty":-2.182837,"median":-1.832728,"eighty":-1.317621,"marketCap":14227727},{"date":"2023-09-22","current":-0.943498,"twenty":-2.157356,"median":-1.828939,"eighty":-1.314844,"marketCap":9309500},{"date":"2023-09-29","current":-1.032507,"twenty":-2.13103,"median":-1.825151,"eighty":-1.294017,"marketCap":10187755},{"date":"2023-10-06","current":-1.201625,"twenty":-2.129337,"median":-1.825151,"eighty":-1.278744,"marketCap":11856439},{"date":"2023-10-13","current":-1.183912,"twenty":-2.127644,"median":-1.825151,"eighty":-1.266525,"marketCap":11681667},{"date":"2023-10-20","current":-1.201625,"twenty":-2.127644,"median":-1.818844,"eighty":-1.249588,"marketCap":11856439},{"date":"2023-10-27","current":-1.326238,"twenty":-2.127644,"median":-1.816544,"eighty":-1.252365,"marketCap":13085996},{"date":"2023-11-03","current":-1.148219,"twenty":-2.126306,"median":-1.810749,"eighty":-1.249588,"marketCap":11329486},{"date":"2023-11-10","current":-1.317337,"twenty":-2.123935,"median":-1.80496,"eighty":-1.242173,"marketCap":12998171},{"date":"2023-11-17","current":-1.735051,"twenty":-2.120976,"median":-1.80496,"eighty":-1.249588,"marketCap":12559043},{"date":"2023-11-24","current":-1.837849,"twenty":-2.117339,"median":-1.80496,"eighty":-1.249588,"marketCap":13303140},{"date":"2023-12-01","current":-2.179164,"twenty":-2.117339,"median":-1.806544,"eighty":-1.249588,"marketCap":15773723},{"date":"2023-12-08","current":-1.995379,"twenty":-2.117339,"median":-1.813341,"eighty":-1.249588,"marketCap":14443409},{"date":"2023-12-15","current":-1.890359,"twenty":-2.11519,"median":-1.816544,"eighty":-1.250976,"marketCap":13683229},{"date":"2023-12-22","current":-1.916614,"twenty":-2.106539,"median":-1.824721,"eighty":-1.256675,"marketCap":13873274},{"date":"2023-12-29","current":-2.192291,"twenty":-2.117284,"median":-1.825151,"eighty":-1.257111,"marketCap":15868745},{"date":"2024-01-05","current":-1.916614,"twenty":-2.117321,"median":-1.825151,"eighty":-1.259926,"marketCap":13873274},{"date":"2024-01-12","current":-2.094491,"twenty":-2.113114,"median":-1.825151,"eighty":-1.266525,"marketCap":15160828},{"date":"2024-01-19","current":-2.01507,"twenty":-2.106539,"median":-1.832728,"eighty":-1.270414,"marketCap":14585943},{"date":"2024-01-26","current":-2.080707,"twenty":-2.104197,"median":-1.835522,"eighty":-1.271503,"marketCap":15061055},{"date":"2024-02-02","current":-2.021634,"twenty":-2.104197,"median":-1.837849,"eighty":-1.277052,"marketCap":14633454},{"date":"2024-02-09","current":-2.061016,"twenty":-2.100399,"median":-1.837849,"eighty":-1.281982,"marketCap":14918521},{"date":"2024-02-16","current":-1.982251,"twenty":-2.100399,"median":-1.839671,"eighty":-1.282958,"marketCap":14348386},{"date":"2024-02-23","current":-1.864104,"twenty":-2.100399,"median":-1.844413,"eighty":-1.284298,"marketCap":13493185},{"date":"2024-03-01","current":-3.045578,"twenty":-2.106887,"median":-1.846747,"eighty":-1.29124,"marketCap":22045203},{"date":"2024-03-08","current":-2.034761,"twenty":-2.117357,"median":-1.850976,"eighty":-1.299535,"marketCap":14728476},{"date":"2024-03-15","current":-2.799727,"twenty":-2.127644,"median":-1.85621,"eighty":-1.299535,"marketCap":20265625},{"date":"2024-03-22","current":-3.226804,"twenty":-2.174343,"median":-1.857797,"eighty":-1.305125,"marketCap":23356992},{"date":"2024-03-28","current":-3.290074,"twenty":-2.197195,"median":-1.866632,"eighty":-1.310679,"marketCap":23814972},{"date":"2024-04-05","current":-3.721769,"twenty":-2.225304,"median":-1.875692,"eighty":-1.312067,"marketCap":29539725},{"date":"2024-04-12","current":-3.409184,"twenty":-2.252484,"median":-1.878554,"eighty":-1.316283,"marketCap":27058731},{"date":"2024-04-19","current":-4.047499,"twenty":-2.337419,"median":-1.887373,"eighty":-1.317337,"marketCap":32125047},{"date":"2024-04-26","current":-3.496227,"twenty":-2.358916,"median":-1.888933,"eighty":-1.318675,"marketCap":27749593},{"date":"2024-05-03","current":-3.322141,"twenty":-2.371393,"median":-1.894051,"eighty":-1.319009,"marketCap":26367870},{"date":"2024-05-10","current":-2.930448,"twenty":-2.380496,"median":-1.903486,"eighty":-1.324792,"marketCap":23258995},{"date":"2024-05-17","current":-3.371987,"twenty":-2.422355,"median":-1.908084,"eighty":-1.34267,"marketCap":28210167},{"date":"2024-05-24","current":-3.38575,"twenty":-2.456329,"median":-1.916614,"eighty":-1.363439,"marketCap":28325310},{"date":"2024-05-31","current":-3.330698,"twenty":-2.475014,"median":-1.920868,"eighty":-1.369487,"marketCap":27864736},{"date":"2024-06-07","current":-3.126113,"twenty":-2.555469,"median":-1.925914,"eighty":-1.381356,"marketCap":26462608},{"date":"2024-06-14","current":-2.936249,"twenty":-2.635174,"median":-1.928853,"eighty":-1.388459,"marketCap":24564761},{"date":"2024-06-21","current":-2.591791,"twenty":-2.696804,"median":-1.932424,"eighty":-1.389875,"marketCap":21683018},{"date":"2024-06-28","current":-2.968019,"twenty":-2.720158,"median":-1.935984,"eighty":-1.392624,"marketCap":24830553},{"date":"2024-07-05","current":-3.023756,"twenty":-2.794585,"median":-1.942395,"eighty":-1.395373,"marketCap":25296855},{"date":"2024-07-12","current":-3.399984,"twenty":-2.87532,"median":-1.950745,"eighty":-1.39815,"marketCap":28444390},{"date":"2024-07-15","current":-3.567196,"twenty":-2.892729,"median":-1.953371,"eighty":-1.399538,"marketCap":29843294},{"date":"2024-08-02","current":-3.316378,"twenty":-2.907236,"median":-1.955996,"eighty":-1.400927,"marketCap":27744938},{"date":"2024-08-09","current":-2.533442,"twenty":-2.889827,"median":-1.959964,"eighty":-1.402315,"marketCap":21194865},{"date":"2024-08-16","current":-2.384759,"twenty":-2.863715,"median":-1.969124,"eighty":-1.407869,"marketCap":20833589},{"date":"2024-08-23","current":-2.678705,"twenty":-2.829511,"median":-1.969729,"eighty":-1.414811,"marketCap":23401547},{"date":"2024-08-30","current":-2.393496,"twenty":-2.820363,"median":-1.976948,"eighty":-1.421809,"marketCap":20909923},{"date":"2024-09-06","current":-2.138705,"twenty":-2.807777,"median":-1.982251,"eighty":-1.427335,"marketCap":18684028},{"date":"2024-09-13","current":-2.547915,"twenty":-2.792014,"median":-1.989241,"eighty":-1.434249,"marketCap":22258950},{"date":"2024-09-20","current":-3.103824,"twenty":-2.814197,"median":-1.994133,"eighty":-1.43998,"marketCap":27115448},{"date":"2024-09-27","current":-3.042056,"twenty":-2.869518,"median":-1.995379,"eighty":-1.455656,"marketCap":26575837},{"date":"2024-10-04","current":-2.887637,"twenty":-2.923292,"median":-1.995379,"eighty":-1.483558,"marketCap":25226810},{"date":"2024-10-11","current":-2.980289,"twenty":-2.932768,"median":-2.002272,"eighty":-1.506321,"marketCap":26036226},{"date":"2024-10-18","current":-3.289127,"twenty":-2.972927,"median":-2.01507,"eighty":-1.523838,"marketCap":28734281},{"date":"2024-10-25","current":-1.992007,"twenty":-2.956851,"median":-2.021634,"eighty":-1.532989,"marketCap":17402452},{"date":"2024-10-31","current":-2.115542,"twenty":-2.944143,"median":-2.021634,"eighty":-1.536549,"marketCap":18481674},{"date":"2024-11-08","current":-2.038332,"twenty":-2.933929,"median":-2.021634,"eighty":-1.53986,"marketCap":17807160},{"date":"2024-11-15","current":-2.053774,"twenty":-2.925677,"median":-2.02191,"eighty":-1.53986,"marketCap":17942063},{"date":"2024-11-22","current":-2.278807,"twenty":-2.911686,"median":-2.025706,"eighty":-1.540379,"marketCap":19247024},{"date":"2024-11-29","current":-2.241903,"twenty":-2.898674,"median":-2.034761,"eighty":-1.544459,"marketCap":18935331},{"date":"2024-12-06","current":-1.946673,"twenty":-2.887637,"median":-2.034498,"eighty":-1.559915,"marketCap":16441789},{"date":"2024-12-13","current":-1.796844,"twenty":-2.887495,"median":-2.025706,"eighty":-1.574592,"marketCap":15176317},{"date":"2024-12-20","current":-2.177321,"twenty":-2.881123,"median":-2.023021,"eighty":-1.597881,"marketCap":18389869},{"date":"2024-12-27","current":-1.752928,"twenty":-2.857912,"median":-2.021634,"eighty":-1.600387,"marketCap":14805403},{"date":"2025-01-03","current":-1.734661,"twenty":-2.856986,"median":-2.021634,"eighty":-1.60117,"marketCap":14651115},{"date":"2025-01-10","current":-1.699602,"twenty":-2.836148,"median":-2.018352,"eighty":-1.601847,"marketCap":14355007},{"date":"2025-01-17","current":-1.335731,"twenty":-2.820875,"median":-2.007448,"eighty":-1.564421,"marketCap":11281717},{"date":"2025-01-24","current":-1.163022,"twenty":-2.816082,"median":-2.001445,"eighty":-1.53986,"marketCap":9822995},{"date":"2025-01-31","current":-1.429282,"twenty":-2.810428,"median":-1.995379,"eighty":-1.520278,"marketCap":12071858},{"date":"2025-02-07","current":-1.549958,"twenty":-2.806148,"median":-1.995379,"eighty":-1.476717,"marketCap":13091093},{"date":"2025-02-14","current":-1.47615,"twenty":-2.794585,"median":-1.993467,"eighty":-1.461865,"marketCap":12467708},{"date":"2025-02-21","current":-1.494602,"twenty":-2.780852,"median":-1.992007,"eighty":-1.460888,"marketCap":12623554},{"date":"2025-02-28","current":-0.963926,"twenty":-2.75515,"median":-1.991074,"eighty":-1.443623,"marketCap":8141413},{"date":"2025-03-07","current":-0.701171,"twenty":-2.745155,"median":-1.982251,"eighty":-1.43747,"marketCap":5922161},{"date":"2025-03-14","current":-0.653934,"twenty":-2.729886,"median":-1.976948,"eighty":-1.424425,"marketCap":5523194},{"date":"2025-03-21","current":-0.517575,"twenty":-2.72248,"median":-1.97152,"eighty":-1.402315,"marketCap":4371490},{"date":"2025-03-28","current":-0.499123,"twenty":-2.711125,"median":-1.969124,"eighty":-1.395373,"marketCap":4215643},{"date":"2025-04-04","current":-1.208694,"twenty":-2.703877,"median":-1.960774,"eighty":-1.389313,"marketCap":10926387},{"date":"2025-04-11","current":-1.109488,"twenty":-2.699246,"median":-1.959964,"eighty":-1.373373,"marketCap":10029580},{"date":"2025-04-17","current":-0.930218,"twenty":-2.686893,"median":-1.950745,"eighty":-1.346778,"marketCap":8409017},{"date":"2025-04-25","current":-1.014207,"twenty":-2.686893,"median":-1.946121,"eighty":-1.319009,"marketCap":9168264},{"date":"2025-05-02","current":-0.940915,"twenty":-2.678705,"median":-1.937447,"eighty":-1.312067,"marketCap":8505714},{"date":"2025-05-09","current":-0.399146,"twenty":-2.678705,"median":-1.932424,"eighty":-1.305125,"marketCap":3608213},{"date":"2025-05-16","current":-0.407268,"twenty":-2.671451,"median":-1.928853,"eighty":-1.284298,"marketCap":3681631},{"date":"2025-05-23","current":-0.516082,"twenty":-2.666968,"median":-1.922976,"eighty":-1.270414,"marketCap":5025828},{"date":"2025-05-30","current":-0.966696,"twenty":-2.661906,"median":-1.920831,"eighty":-1.257111,"marketCap":9414103},{"date":"2025-06-06","current":-0.795486,"twenty":-2.650151,"median":-1.918995,"eighty":-1.249588,"marketCap":7746784},{"date":"2025-06-13","current":-0.8622,"twenty":-2.635522,"median":-1.912853,"eighty":-1.244287,"marketCap":8396479},{"date":"2025-06-20","current":-0.709831,"twenty":-2.618725,"median":-1.905402,"eighty":-1.232242,"marketCap":6912642},{"date":"2025-06-27","current":-1.017396,"twenty":-2.598886,"median":-1.897743,"eighty":-1.214877,"marketCap":9907846},{"date":"2025-07-03","current":-0.770044,"twenty":-2.591483,"median":-1.890359,"eighty":-1.208239,"marketCap":7499020},{"date":"2025-07-11","current":-0.876335,"twenty":-2.59102,"median":-1.888153,"eighty":-1.201625,"marketCap":8534127},{"date":"2025-07-18","current":-0.938243,"twenty":-2.589606,"median":-1.887373,"eighty":-1.20002,"marketCap":9137021},{"date":"2025-07-25","current":-0.981212,"twenty":-2.579124,"median":-1.880624,"eighty":-1.19405,"marketCap":9555469},{"date":"2025-08-01","current":-0.896123,"twenty":-2.566585,"median":-1.877002,"eighty":-1.178613,"marketCap":8726833},{"date":"2025-08-08","current":-0.805605,"twenty":-2.564843,"median":-1.871631,"eighty":-1.166282,"marketCap":7845335},{"date":"2025-08-15","current":-0.734514,"twenty":-2.556562,"median":-1.864104,"eighty":-1.153024,"marketCap":7153017},{"date":"2025-08-22","current":-0.600416,"twenty":-2.548001,"median":-1.856262,"eighty":-1.147852,"marketCap":7018232},{"date":"2025-08-29","current":-0.589686,"twenty":-2.542126,"median":-1.850976,"eighty":-1.141773,"marketCap":6892806},{"date":"2025-09-05","current":-0.576786,"twenty":-2.527872,"median":-1.850976,"eighty":-1.132959,"marketCap":6742012},{"date":"2025-09-12","current":-0.614643,"twenty":-2.504791,"median":-1.845892,"eighty":-1.112133,"marketCap":7184527},{"date":"2025-09-19","current":-0.407752,"twenty":-2.500691,"median":-1.839671,"eighty":-1.104939,"marketCap":4766194},{"date":"2025-09-26","current":-0.284782,"twenty":-2.496685,"median":-1.838551,"eighty":-1.072491,"marketCap":3328801},{"date":"2025-10-03","current":-0.232168,"twenty":-2.492051,"median":-1.837849,"eighty":-1.056595,"marketCap":2713802},{"date":"2025-10-10","current":-0.24219,"twenty":-2.479261,"median":-1.835522,"eighty":-1.025248,"marketCap":2830945},{"date":"2025-10-17","current":-1.309651,"twenty":-2.475863,"median":-1.832728,"eighty":-1.022005,"marketCap":15308437}],"updateTime":1760809295949},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIAF\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2570614839","title":"bioAffinity Stock Up Over 50%: What's Driving the Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2570614839","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570614839?lang=en_us&edition=fundamental","pubTime":"2025-09-27 02:06","pubTimestamp":1758909960,"startTime":"0","endTime":"0","summary":"Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studies affirming the performance of one of its products</","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/26/lab--Medical-Hospital-Research-Laborator.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/26/lab--Medical-Hospital-Research-Laborator.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/09/47897809/bioaffinity-stock-up-nearly-90-whats-driving-the-surge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/09/47897809/bioaffinity-stock-up-nearly-90-whats-driving-the-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2570888083","title":"bioAffinity Technologies Announces New Clinical Case Studies Demonstrating CyPath® Lung's Success in Early-Stage Cancer Detection and Reducing Unnecessary Procedures","url":"https://stock-news.laohu8.com/highlight/detail?id=2570888083","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570888083?lang=en_us&edition=fundamental","pubTime":"2025-09-26 20:00","pubTimestamp":1758888037,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Announces New Clinical Case Studies Demonstrating CyPath Lung's Success in Early-Stage Cancer Detection and Reducing Unnecessary Procedures. bioAffinity Technologies Inc. has announced the release of three new case studies demonstrating the clinical utility of its CyPath Lung diagnostic test. The cases include detection of Stage 1A lung cancer following a positive CyPath Lung result, as well as instances where the test helped avoid unnecessary invasive procedures in patients with indeterminate pulmonary nodules. According to the company, these case studies were provided by a Texas pulmonologist who has been using CyPath Lung for over a year. The results from these cases have already been released by bioAffinity Technologies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDLb9MCym:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2570304044","title":"bioAffinity Technologies Inc. Files Initial Statement of Beneficial Ownership for Director John J. Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2570304044","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570304044?lang=en_us&edition=fundamental","pubTime":"2025-09-26 05:17","pubTimestamp":1758835052,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists John J. Oppenheimer as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL7TlQ2Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2568598284","title":"bioAffinity Technologies Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2568598284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568598284?lang=en_us&edition=fundamental","pubTime":"2025-09-19 07:50","pubTimestamp":1758239417,"startTime":"0","endTime":"0","summary":"19:50 EDT bioAffinity Technologies (BIAF) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-mo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2568496195","title":"BioAffinity Technologies announces 1-for-30 reverse split","url":"https://stock-news.laohu8.com/highlight/detail?id=2568496195","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568496195?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:30","pubTimestamp":1758112235,"startTime":"0","endTime":"0","summary":"BioAffinity Technologies (BIAF) announced that it will effect a 1-for-30 reverse split of its common stock. Commencing with the opening of trading ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-announces-1-for-30-reverse-split-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-announces-1-for-30-reverse-split-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2568349543","title":"bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2568349543","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568349543?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:15","pubTimestamp":1758111300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUABKKWSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"2560618549","title":"BRIEF-Bioaffinity Technologies Appoints New Members To Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2560618549","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560618549?lang=en_us&edition=fundamental","pubTime":"2025-08-18 22:19","pubTimestamp":1755526769,"startTime":"0","endTime":"0","summary":"BRIEF-Bioaffinity Technologies Appoints New Members To Board Of DirectorsAug 18 (Reuters) - bioAffinity Technologies Inc BIAF.O:BIOAFFINITY TECHNOLOGIES APPOINTS NEW MEMBERS TO BOARD OF DIRECTORSSource text: ID:nBw3pqQBJaFurther company coverage: BIAF.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA5FYRM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BIAF","BK4139"],"gpt_icon":0},{"id":"2560021499","title":"bioAffinity Technologies Announces New Board Appointments: Roberto Rios and Dr. John J. Oppenheimer Join as Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2560021499","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560021499?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:01","pubTimestamp":1755518476,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc. has announced the appointment of Roberto Rios, CPA, and John J. Oppenheimer, M.D., to its Board of Directors. These appointments come as the company focuses on increasing sales of CyPath Lung and developing companion diagnostics for asthma and COPD. Concurrently, Gary Rubin has stepped down from the Board for personal reasons.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire  on August 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nNDL9K42Xg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2560902513","title":"bioAffinity Technologies Appoints New Members to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2560902513","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560902513?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:00","pubTimestamp":1755518402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA5FYRM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAF","BK4139","BIAFW"],"gpt_icon":0},{"id":"2559954205","title":"bioAffinity Technologies Reports 62% Increase in CyPath® Lung Revenues for First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559954205","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559954205?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:04","pubTimestamp":1755173064,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire  on August 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL5pKDrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF"],"gpt_icon":0},{"id":"2559954291","title":"bioAffinity Technologies Q2 EPS $(0.17) Misses $(0.10) Estimate, Sales $1.269M Miss $1.506M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559954291","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559954291?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:03","pubTimestamp":1755173011,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.10) by 70 percent. This is a 10.53 percent increase over losses of $(0.19) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47118956/bioaffinity-technologies-q2-eps-0-17-misses-0-10-estimate-sales-1-269m-miss-1-506m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF"],"gpt_icon":0},{"id":"2559760720","title":"bioAffinity Technologies Announces $1.2 Million Private Placement and Warrant Inducement Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2559760720","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559760720?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:25","pubTimestamp":1755091513,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc. , a biotechnology company specializing in noninvasive cancer detection tests, has announced a private placement and warrant inducement transaction expected to generate approximately $1.2 million in gross proceeds. The company has entered into securities purchase agreements with institutional and accredited investors for the sale of 990 shares of its Series B Convertible Preferred Stock and warrants to purchase around 6.7 million shares of common stock. WallachBeth Capital LLC is serving as the sole placement agent and financial advisor for the transaction. The proceeds will be utilized for working capital and general corporate purposes. The closing is anticipated to occur around August 14, 2025, pending customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes onl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDLbVcxQx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2559071266","title":"bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2559071266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559071266?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:25","pubTimestamp":1755091500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA30TYDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"2558705855","title":"bioAffinity Technologies Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2558705855","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558705855?lang=en_us&edition=fundamental","pubTime":"2025-08-09 06:45","pubTimestamp":1754693104,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc  expected to post a loss of10cents a share - Earnings Preview bioAffinity Technologies Inc BIAF.OQ BIAF.O is expected to  show a fall in quarterly revenue when it reports ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U03UF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF"],"gpt_icon":0},{"id":"2555004055","title":"Case Study: Cypath® Lung Detects Stage 1a Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2555004055","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555004055?lang=en_us&edition=fundamental","pubTime":"2025-07-29 20:00","pubTimestamp":1753790401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nTUA5QFDVR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAF","BK4139","BIAFW"],"gpt_icon":0},{"id":"2554133794","title":"bioAffinity Technologies Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2554133794","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554133794?lang=en_us&edition=fundamental","pubTime":"2025-07-26 04:16","pubTimestamp":1753474590,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc. held its 2025 Annual Meeting of Stockholders on July 25, 2025. During the meeting, stockholders voted on several key proposals. The election of seven director nominees to the Board was approved. The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, an amendment to the Company's Certificate of Incorporation to effect a Reverse Stock Split was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL32KXHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2553256691","title":"bioAffinity Technologies Secures Canadian Patent for Innovative Lung Cancer Diagnostic Test, CyPath® Lung","url":"https://stock-news.laohu8.com/highlight/detail?id=2553256691","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553256691?lang=en_us&edition=fundamental","pubTime":"2025-07-22 21:01","pubTimestamp":1753189262,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc. has announced that its patent related to a method for detecting lung disease through flow cytometry analysis of sputum has been allowed by the Canadian Patent Office. This patent enhances the international protection of the company's diagnostic platform, CyPath Lung, a noninvasive lung cancer diagnostic test. The Canadian patent, titled \"System and Method for Determining Lung Health,\" safeguards the use of defined antibodies and the porphyrin TCPP to label cell populations in sputum, and the application of flow cytometry to identify the presence of lung cancer cells. This development further validates the diagnostic platform of CyPath Lung and expands its global intellectual property portfolio.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL7jrgzn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2551918167","title":"bioAffinity Technologies Receives Notification of Patent Allowance in China for Noninvasive Lung Cancer Diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2551918167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551918167?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:01","pubTimestamp":1752584464,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc. has received notification from the China National Intellectual Property Administration regarding the allowance of a patent application related to its noninvasive lung cancer diagnostic methods. This development is significant given China's substantial population of smokers, which contributes to the country's high rate of lung cancer. The patent, titled \"System and Method for Determining Lung Health,\" involves the use of specific antibodies and the porphyrin TCPP to label cell populations in sputum, utilizing flow cytometry to detect lung cancer cells. This notification is part of bioAffinity's strategy to expand its proprietary diagnostic platform internationally.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL5zRssd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2546735799","title":"bioAffinity Technologies Announces Patent Filing for Broad-Spectrum Cancer Therapy Using siRNA Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2546735799","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546735799?lang=en_us&edition=fundamental","pubTime":"2025-06-26 21:01","pubTimestamp":1750942870,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc. has announced the issuance of a U.S. patent for their innovative cancer therapy, which utilizes small interfering RNAs  to target and silence specific cell surface receptors, CD320 and LRP2. This approach has shown promise in selectively killing cancer cells across various types, including lung, breast, prostate, brain, and skin cancers, while sparing normal cells. The company also received notification of a patent grant from the China National Intellectual Property Administration, signaling potential global impact for their therapeutic advancements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDLbHJ5cp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2545280818","title":"bioAffinity Technologies Secures Chinese Patent for Innovative siRNA-Based Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2545280818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545280818?lang=en_us&edition=fundamental","pubTime":"2025-06-24 21:01","pubTimestamp":1750770073,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies Inc. has announced that the China National Intellectual Property Administration has issued a notification of patent grant for the company's novel method and composition aimed at selectively killing cancer cells. The newly granted Chinese patent, titled \"Compositions and Methods for Treating Cancer,\" protects bioAffinity's innovative RNA-based therapeutic strategy, which focuses on targeting the CD320 and LRP2 receptors on cancer cell membranes. This patent enhances global protection for the company's siRNA-based therapies, which have demonstrated effectiveness in causing cancer cell death without affecting normal cells. The technology is being explored for topical treatment applications, particularly for skin cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL63f3S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":50,"code":"91000000","status":"200"}]}}